Physical performance, depresion, immune status and fatigue in patients with hematological malignancies after treatment

Annals of Oncology

Volumn 15, Issue 8, 2004, Pages 1237-1242

  Dimeo, Fernando ^a   Schmittel, A ^a   Fietz, T ^a   Schwartz, S ^a   Kohler P ^a   Boning D ^a   Thiel, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Correlation analysis; Fatigue; Hematological malignancies

Indexed keywords

C REACTIVE PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; NEOPTERIN; CYTOKINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FATIGUE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREACTIVITY; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MOOD; PHYSICAL CAPACITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THYROID FUNCTION; BLOOD DISEASE; DISEASE FREE SURVIVAL; FITNESS; HEALTH STATUS; KIDNEY; LIVER; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; THYROID GLAND;

ADULT; AGED; CYTOKINES; DEPRESSION; DISEASE-FREE SURVIVAL; FATIGUE; FEMALE; HEALTH STATUS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNE SYSTEM; KIDNEY; LIVER; MALE; MIDDLE AGED; PHYSICAL FITNESS; THYROID GLAND;

EID: 4444363002     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh314     Document Type: Article

References (38)

1. National Comprehensive Cancer Network. Cancer-Related Fatigue. National Comprehensive Cancer Network, Inc. 2003; http://www.nccn.org.
2. Smets EMA, Garssen B, Schuster-Uitterhoeve ALJ, de Haes JCJM. Fatigue in cancer patients. Br J Cancer 1993; 68: 220-224.
3. Vogelzang NJ, Breitbart W, Cella D et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997; 34: 4-12.
4. Winningham ML, Nail LM, Barton B et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 1994; 21: 23-36.
5. Devlen J, Maguire P, Phillips P et al. Psychological problems associated with diagnosis and treatment of lymphomas. I: Retrospective study. II: Prospective study. Br Med J 1987; 295: 953-957.
6. Fobair P, Hoppe RT, Bloom J et al. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 1986; 4: 805-814.
7. Dimeo F, Stieglitz RD, Novelli-Fischer U et al. Correlation between physical performance and fatigue in cancer patients. Ann Oncol 1997; 8: 1251-1255.
8. Morrow GR, Hickok JT, Roscoe JA et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Centre Community Clinical Oncology Program. J Clin Oncol 2003; 21: 4635-4641.
9. Howell SJ, Radford JA, Ryder WD, Shalet SM et al. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol 1999; 17: 1493-1498.
10. Howell SJ, Radford JA, Smets EM. Shalet SM, Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer 2000; 82: 789-793.
11. Mock V, Atkinson A, Barsevick A et al. NCCN practice guidelines for cancer-related fatigue. Oncology 2000; 14: 151-161.
12. Bajorunas DR. Disorders of endocrine function following cancer therapies. Clin Endocrinol Metab 1980; 9: 405-430.
13. Smolarz K, Malke G, Voth E et al. Hypothyroidism after therapy for larynx and pharynx carcinoma. Thyroid 2000; 10: 425-429.
14. Malik UR, Makower DF, Wadler S. Interferon-mediated fatigue. Cancer 2001; 92: 1664-1668.
15. Cohen A, Rovelli R, Zecca S et al. Endocrine late effects in children who underwent bone marrow transplantation: review. Bone Marrow Transplant 1998; 21 (Suppl 2): S64-S67.
16. Knobel H, Havard LJ, Brit LM et al. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 2001; 19: 3226-3233.
17. Bruera E, Brenneis C, Michaud M et al. Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer. J Pain Symptom Manage 1989; 4: 59-63.
18. Geinitz H, Zimmermann FB, Stoll P et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 2001; 51: 691-698.
19. Wang XS, Giralt SA, Mendoza TR et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol 2002; 20: 1319-1328.
20. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92: 1684-1688.
21. Cannon JG, Angel JB, Ball RW et al. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999; 19: 414-421.
22. Seymour JF, Talpaz M, Cabanillas F et al. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol 1995; 13: 575-582.
23. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604-611.
24. Yellen SB, Cella DF, Webster K et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13: 63-74.
25. Radloff LS. A self-report depression scale for research in the general population. J Appl Psychol Measure 1977; 1: 385-401.
26. Ainsworth BE, Haskell WL, Leon AS et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-80.
27. Courneya KS, Mackey JR, Bell GJ et al. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003; 21: 1660-1669.
28. Segal R, Evans W, Johnson D et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001; 19: 657-665.
29. Segal RJ, Reid RD, Courneya KS et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653-1659.
30. Mock V, Dow KH, Meares CJ et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997; 24: 991-1000.
31. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. Philadelphia, PA: Lea, Feibiger 1995.
32. Metra M, Nodari S, Raccagni D et al. Maximal and submaximal exercise testing in heart failure. J Cardiovasc Pharmacol 1998; 32 (Suppl. 1): S36-S45.
33. Fawzy NW. A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients. Cancer Nurs 1995; 18: 427-438.
34. Gaston-Johansson F, Fall-Dickson JM, Nanda J et al. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs 2000; 23: 277-285.
35. Jacobsen PB, Meade CD, Stein KD et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 2002; 20: 2851-2862.
36. Littlewood TJ, Bajetta E, Nortier JW et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19: 2865-2874.
37. Iconomou G, Koutras A, Rigopoulos A et al. Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial. J Pain Symptom Manage 2003; 25: 512-518.
38. Hedenus M, Adriansson M, San Miguel J et al. Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study. Br J Haematol 2003; 122: 394-403.